Literature DB >> 28003856

Exact p-values for Simon's two-stage designs in clinical trials.

Guogen Shan1, Hua Zhang2, Tao Jiang2, Hanna Peterson1, Daniel Young1, Changxing Ma3.   

Abstract

In a one-sided hypothesis testing problem in clinical trials, the monotonic condition of a tail probability function is fundamentally important to guarantee that the actual type I and II error rates occur at the boundary of their associated parameter spaces. Otherwise, one has to search for the actual rates over the complete parameter space, which could be very computationally intensive. This important property has been extensively studied in traditional one-stage study settings (e.g., non-inferiority or superiority between two binomial proportions), but there is very limited research for this property in a two-stage design setting, e.g., Simon's two-stage design. In this note, we theoretically prove that the tail probability is an increasing function of the parameter in Simon's two-stage design. This proof not only provides theoretical justification that p-value occurs at the boundary of the parameter space, but also helps to reduce the computational intensity for study design search.

Entities:  

Keywords:  Boundary; Mathematical induction; Monotonic condition; Simon’s two-stage design

Year:  2016        PMID: 28003856      PMCID: PMC5167475          DOI: 10.1007/s12561-016-9152-1

Source DB:  PubMed          Journal:  Stat Biosci        ISSN: 1867-1764


  11 in total

1.  On the estimation of the binomial probability in multistage clinical trials.

Authors:  Sin-Ho Jung; Kyung Mann Kim
Journal:  Stat Med       Date:  2004-03-30       Impact factor: 2.373

2.  Unconditional tests for comparing two ordered multinomials.

Authors:  Guogen Shan; Changxing Ma
Journal:  Stat Methods Med Res       Date:  2012-06-13       Impact factor: 3.021

3.  Problems with existing procedures to calculate exact unconditional P-values for non-inferiority/superiority and confidence intervals for two binomials and how to resolve them.

Authors:  Joachim Röhmel
Journal:  Biom J       Date:  2005-02       Impact factor: 2.207

4.  The design of single-arm clinical trials of combination antiretroviral regimens for treatment-naive HIV-infected patients.

Authors:  Lu Zheng; Susan L Rosenkranz; Babafemi Taiwo; Michael F Para; Joseph J Eron; Michael D Hughes
Journal:  AIDS Res Hum Retroviruses       Date:  2013-01-09       Impact factor: 2.205

5.  Guidelines for the diagnosis and management of gastroesophageal reflux disease.

Authors:  Philip O Katz; Lauren B Gerson; Marcelo F Vela
Journal:  Am J Gastroenterol       Date:  2013-02-19       Impact factor: 10.864

6.  Optimal two-stage designs for phase II clinical trials.

Authors:  R Simon
Journal:  Control Clin Trials       Date:  1989-03

7.  A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced urothelial cancer: final results.

Authors:  Arlene O Siefker-Radtke; Colin P Dinney; Yu Shen; Dallas L Williams; Ashish M Kamat; H Barton Grossman; Randall E Millikan
Journal:  Cancer       Date:  2012-08-22       Impact factor: 6.860

8.  Linear combinations of biomarkers to improve diagnostic accuracy with three ordinal diagnostic categories.

Authors:  Le Kang; Chengjie Xiong; Paul Crane; Lili Tian
Journal:  Stat Med       Date:  2012-08-03       Impact factor: 2.373

9.  Boundary problem in Simon's two-stage clinical trial designs.

Authors:  Guogen Shan; John J Chen; Changxing Ma
Journal:  J Biopharm Stat       Date:  2016-02-16       Impact factor: 1.051

10.  Optimal adaptive two-stage designs for early phase II clinical trials.

Authors:  Guogen Shan; Gregory E Wilding; Alan D Hutson; Shawn Gerstenberger
Journal:  Stat Med       Date:  2015-11-03       Impact factor: 2.373

View more
  8 in total

1.  Optimal inference for Simon's two-stage design with over or under enrollment at the second stage.

Authors:  Guogen Shan; John J Chen
Journal:  Commun Stat Simul Comput       Date:  2017-06-20       Impact factor: 1.118

2.  Conservative confidence intervals for the intraclass correlation coefficient for clustered binary data.

Authors:  Guogen Shan
Journal:  J Appl Stat       Date:  2021-04-02       Impact factor: 1.416

3.  Statistical advances in clinical trials and clinical research.

Authors:  Guogen Shan; Sarah Banks; Justin B Miller; Aaron Ritter; Charles Bernick; Joseph Lombardo; Jeffrey L Cummings
Journal:  Alzheimers Dement (N Y)       Date:  2018-06-14

4.  Optimal two-stage design of single arm Phase II clinical trials based on median event time test.

Authors:  Yeonhee Park
Journal:  PLoS One       Date:  2021-02-08       Impact factor: 3.240

5.  Machine learning methods to predict amyloid positivity using domain scores from cognitive tests.

Authors:  Guogen Shan; Charles Bernick; Jessica Z K Caldwell; Aaron Ritter
Journal:  Sci Rep       Date:  2021-03-01       Impact factor: 4.379

6.  Monte Carlo cross-validation for a study with binary outcome and limited sample size.

Authors:  Guogen Shan
Journal:  BMC Med Inform Decis Mak       Date:  2022-10-17       Impact factor: 3.298

7.  Fisher's exact approach for post hoc analysis of a chi-squared test.

Authors:  Guogen Shan; Shawn Gerstenberger
Journal:  PLoS One       Date:  2017-12-20       Impact factor: 3.240

8.  Correlation Coefficients for a Study with Repeated Measures.

Authors:  Guogen Shan; Hua Zhang; Tao Jiang
Journal:  Comput Math Methods Med       Date:  2020-03-26       Impact factor: 2.238

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.